SBS:ETR
Stratec SE
€21,70
arrow_upward
+0,23%(+0,050) 1D
2 Okt., 17:35:29 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SBS...
Open
€21,60
High
€21,90
Low
€21,00
Mkt. cap
252,50Â m
Avg. vol.
12,38Â k
Volume
6,26Â k
Dividend
2,76%
Quarterly dividend
€0,15
Ex-dividend date
24 Jun. 2026
52-wk high
€33,10
52-wk low
€16,30
EPS
-€0,03
Shares outstanding
12,16Â m
No. of employees
1Â k
Open
€21,60
High
€21,90
Low
€21,00
Mkt. cap
252,50Â m
Avg. vol.
12,38Â k
Volume
6,26Â k
Dividend
2,76%
Quarterly dividend
€0,15
Ex-dividend date
24 Jun. 2026
52-wk high
€33,10
52-wk low
€16,30
EPS
-€0,03
Shares outstanding
12,16Â m
No. of employees
1Â k
News stories
From web sources and news partners
AD HOC NEWS
·
3 uur gelede
Stratec stock reports a Q2 recovery as execution risks rise
AD HOC NEWS
·
12 uur gelede
Stratec reports voting rights change and Stratec stock costs EUR 21.73
Profile
STRATEC SE is a company with worldwide operations that designs and manufactures fully automated analyzer systems for partners in clinical diagnostics and biotechnology - particularly in the field of in-vitro-diagnostics.
As a classic original equipment manufacturer supplier, STRATEC produces its systems almost exclusively on behalf of its customers. Alongside the systems themselves, the company also provides sample preparation solutions, system software and integrated laboratory software. STRATEC is also responsible for development documentation, testing, delivery of systems, and the supply of spare parts and complex consumables for diagnostic and medical applications. STRATEC's customers are well known diagnostic companies like DiaSorin, Abbott, SIEMENS, Bio-Rad or Hologic. Wikipedia
About Stratec SE